Thymoglobulin
E1550581
UNEXPLORED
Thymoglobulin is an immunosuppressive anti-thymocyte globulin used primarily to prevent and treat acute rejection in organ transplantation.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Thymoglobulin canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22717595 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Thymoglobulin Context triple: [Genzyme, hasProduct, Thymoglobulin]
-
A.
Rituxan
Rituxan is a monoclonal antibody drug (rituximab) widely used to treat certain blood cancers and autoimmune diseases by targeting the CD20 protein on B cells.
-
B.
Ofatumumab
Ofatumumab is a fully human monoclonal antibody used primarily in the treatment of certain B‑cell malignancies and relapsing forms of multiple sclerosis.
-
C.
mycophenolate mofetil
Mycophenolate mofetil is an immunosuppressive medication commonly used to prevent organ transplant rejection and to treat various autoimmune diseases.
-
D.
cyclosporine A
Cyclosporine A is an immunosuppressant drug widely used to prevent organ transplant rejection and treat certain autoimmune diseases.
-
E.
Kymriah
Kymriah is a pioneering CAR-T cell therapy used to treat certain types of blood cancers by genetically modifying a patient’s own immune cells to target and destroy malignant cells.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Thymoglobulin Target entity description: Thymoglobulin is an immunosuppressive anti-thymocyte globulin used primarily to prevent and treat acute rejection in organ transplantation.
-
A.
Rituxan
Rituxan is a monoclonal antibody drug (rituximab) widely used to treat certain blood cancers and autoimmune diseases by targeting the CD20 protein on B cells.
-
B.
Ofatumumab
Ofatumumab is a fully human monoclonal antibody used primarily in the treatment of certain B‑cell malignancies and relapsing forms of multiple sclerosis.
-
C.
mycophenolate mofetil
Mycophenolate mofetil is an immunosuppressive medication commonly used to prevent organ transplant rejection and to treat various autoimmune diseases.
-
D.
cyclosporine A
Cyclosporine A is an immunosuppressant drug widely used to prevent organ transplant rejection and treat certain autoimmune diseases.
-
E.
Kymriah
Kymriah is a pioneering CAR-T cell therapy used to treat certain types of blood cancers by genetically modifying a patient’s own immune cells to target and destroy malignant cells.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.